References
- Ariga, T., Miyatake, T., and Yu, R.K. (2001). Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders. J. Neurosci. Res. 65, 363-370. https://doi.org/10.1002/jnr.1162
- Brunetti-Pierri, N., and Scaglia, F. (2008). GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol. Genet. Metab. 94, 391-396. https://doi.org/10.1016/j.ymgme.2008.04.012
- Campbell, M.J., and Morrison, J.H. (1989). Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J. Comp. Neurol. 282, 191-205. https://doi.org/10.1002/cne.902820204
- Chen, Y., Balasubramaniyan, V., Peng, J., Hurlock, E.C., Tallquist, M., Li, J., and Lu, Q.R. (2007). Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2, 1044-1051. https://doi.org/10.1038/nprot.2007.149
- Di Rocco, M., Dardis, A., Madeo, A., Barone, R., and Fiumara, A. (2012). Early miglustat therapy in infantile Niemann-Pick disease type C. Pediatr. Neurol. 47, 40-43. https://doi.org/10.1016/j.pediatrneurol.2012.04.005
- Fishman, P.H., and Brady, R.O. (1976). Biosynthesis and function of gangliosides. Science 194, 906-915. https://doi.org/10.1126/science.185697
- Futerman, A.H., and van Meer, G. (2004). The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell. Biol. 5, 554-565.20. https://doi.org/10.1038/nrm1423
- German, D.C., Liang, C.L., Song, T., Yazdani, U., Xie, C., and Dietschy, J.M. (2002). Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 109, 437-450. https://doi.org/10.1016/S0306-4522(01)00517-6
- Gondre-Lewis, M.C., McGlynn, R., and Walkley, S.U. (2003). Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr. Biol. 13, 1324-1329. https://doi.org/10.1016/S0960-9822(03)00531-1
- Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., et al. (2004). A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 4894-4902. https://doi.org/10.1523/JNEUROSCI.0861-04.2004
- He, X., Dagan, A., Gatt, S., and Schuchman, E.H. (2005). Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase. Anal. Biochem. 340, 113-122. https://doi.org/10.1016/j.ab.2005.01.058
- Karimzadeh, P., Tonekaboni, S.H., Ashrafi, M.R., Shafeghati, Y., Rezayi, A., Salehpour, S., Ghofrani, M., Taghdiri, M.M., Rahmanifar, A., Zaman, T., et al. (2013). Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: iranian pediatric case series. J. Child Neuol. 28, 1599-1606.
- Lachmann, R.H., te Vruchte, D., Lloyd-Evans, E., Reinkensmeier, G., Sillence, D.J., Fernandez-Guillen, L., Dwek, R.A., Butters, T.D., Cox, T.M., and Platt, F.M. (2004). Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol. Dis. 16, 654-658. https://doi.org/10.1016/j.nbd.2004.05.002
- Lee, H., Lee, J.K., Min, W.K., Bae, J.H., He, X., Schuchman, E.H., Bae, J.S., and Jin, H.K. (2010). Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. Stem Cells 28, 821-831. https://doi.org/10.1002/stem.401
- Lehmann, F., Wegerhoff, R., Rosenberg, A., Schauer, R., and Kohla, G. (2003). Early variations of the disialoganglioside GD3 in chicken embryonic brain support its role in cell migration. Biochimie 85, 449-454. https://doi.org/10.1016/S0300-9084(03)00077-4
- Liu, B., Turley, S.D., Burns, D.K., Miller, A.M., Repa, J.J., and Dietschy, J.M. (2009). Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc. Natl. Acad. Sci. USA 106, 2377-2382. https://doi.org/10.1073/pnas.0810895106
- Loftus, S.K., Morris, J.A., Carstea, E.D., Gu, J.Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M.A., Tagle, D.A., et al. (1997). Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277, 232-235. https://doi.org/10.1126/science.277.5323.232
- Paciorkowski, A.R., Westwell, M., Ounpuu, S., Bell, K., Kagan, J., Mazzarella, C., and Greenstein, R.M. (2008). Motion analysis of a child with Niemann-Pick disease type C treated with miglustat. Movement Disord. 23, 124-128. https://doi.org/10.1002/mds.21779
- Ridgway, N.D. (2000). Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim. Biophys. Acta 1484, 129-141. https://doi.org/10.1016/S1388-1981(00)00006-8
- Rosenbaum, A.I., and Maxfield, F.R. (2011). Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J. Neurochem. 116, 789-795. https://doi.org/10.1111/j.1471-4159.2010.06976.x
- Runz, H., Dolle, D., Schlitter, A.M., and Zschocke, J. (2008). NPCdb, a Niemann-Pick type C disease gene variation database. Hum. Mutat. 29, 345-350. https://doi.org/10.1002/humu.20636
- Saadat, L., Dupree, J.L., Kilkus, J., Han. X., Traka, M., Proia, R.L., Dawson, G., and Popko, B. (2010). Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice. Glia 58, 391-398. https://doi.org/10.1002/glia.20930
- Shevchuk, N.A., Hathout, Y., Epifano, O., Su, Y., Liu, Y., Sutherland, M., and Ladisch, S. (2007). Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts. Biochim. Biophys. Acta 1771, 1226-1234. https://doi.org/10.1016/j.bbalip.2007.05.008
- Simons, K., and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572. https://doi.org/10.1038/42408
- Skorpen, J., Helland, I.B., and Tennoe, B. (2012). Use of miglustat in a child with late-infantile-onset Niemann-Pick disease type C and frequent seizures: a case report. J. Med. Case Rep. 6, 383. https://doi.org/10.1186/1752-1947-6-383
- Sonnino, S., Mauri, L., Chigorno, V., Mauri, L., Chigorno, V., and Prinetti, A. (2007). Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R-13R. https://doi.org/10.1093/glycob/cwm030
- Stein, V.M., Crooks, A., Ding, W., Prociuk, M., O'Donnell, P., Bryan, C., Sikora, T., Dingemanse, J., Vanier, M.T., Walkley, S.U., et al. (2012). Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J. Neuropathol. Exp. Neurol. 71, 434-448. https://doi.org/10.1097/NEN.0b013e31825414a6
- Takikita, S., Fukuda, T., Mohri, I., Yagi, T., and Suzuki, K. (2004). Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J. Neuropath. Exp. Neur. 63, 660-673. https://doi.org/10.1093/jnen/63.6.660
- Tamura, H., Takahashi, T., Ban, N., Torisu, H., Ninomiya, H., Takada, G., and Inagaki, N. (2006). Niemann-Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency. Mol. Genet. Metab. 87, 113-121. https://doi.org/10.1016/j.ymgme.2005.07.025
- Vanier, M.T. (2010). Niemann-Pick disease type C. Orphanet. J. Rare. Dis. 5, 16. https://doi.org/10.1186/1750-1172-5-16
- Vanier, M.T., Duthel, S., Rodriguez-Lafrasse, C., Pentchev, P., and Carstea, E.D. (1996). Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. Am. J. Hum. Genet. 58, 118-125.
- Walkley, S.U., Siegel, D.A., Dobrenis, K., and Zervas, M. (1998). GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis. Ann. N.Y. Acad. Sci. 845, 188-199. https://doi.org/10.1111/j.1749-6632.1998.tb09671.x
- Walkley, S.U., Zervas, M., and Wiseman, S. (2000). Gangliosides as modulators of dendritogenesis in normal and storage diseaseaffected pyramidal neurons. Cereb. Cortex 10, 1028-1037. https://doi.org/10.1093/cercor/10.10.1028
- Xu, Y.H., Barnes, S., Sun, Y., and Grabowski, G.A. (2010). Multisystem disorders of glycosphingolipid and ganglioside metabolism. J. Lipid Res. 51, 1643-1675. https://doi.org/10.1194/jlr.R003996
- Yang, T., Knowles, J.K., Lu, Q., Zhang, H., Arancio, O., Moore, L.A., Chang, T., Wang, Q., Andreasson, K., Rajadas, J., et al. (2008). Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS One 3, e3604. https://doi.org/10.1371/journal.pone.0003604
- Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J.L., Werth, N., et al. (2003). Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. USA 100, 3445-3449. https://doi.org/10.1073/pnas.0635898100
- Yoshikawa, M., Go, S., Takasaki, K., Kakazu, Y., Ohashi, M., Nagafuku, M., Kabayama, K., Sekimoto, J., Suzuki, S., Takaiwa, K., et al. (2009). Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc. Natl. Acad. Sci. USA 106, 9483-9488. https://doi.org/10.1073/pnas.0903279106
- Yu, R.K., Nakatani, Y., and Yanagisawa, M. (2009). The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50 Suppl, S440-445. https://doi.org/10.1194/jlr.R800028-JLR200
- Zervas, M., Dobrenis, K., and Walkley, S.U. (2001a). Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropath. Exp. Neur. 60, 49-64. https://doi.org/10.1093/jnen/60.1.49
- Zervas, M., Somers, K.L., Thrall, M.A., and Walkley, S.U. (2001b). Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr. Biol. 11, 1283-1287. https://doi.org/10.1016/S0960-9822(01)00396-7
Cited by
- Severe demyelination in a patient with a late infantile form of Niemann-Pick disease type C 2017, https://doi.org/10.1111/neup.12380
- Increased Expression of GM1 Detected by Electrospray Mass Spectrometry in Rat Primary Embryonic Cortical Neurons Exposed to Glutamate Toxicity vol.88, pp.15, 2016, https://doi.org/10.1021/acs.analchem.6b01940
- Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APPE693Q mice through reduction of ganglioside-bound Aβ vol.20, pp.1, 2015, https://doi.org/10.1038/mp.2014.135
- Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme vol.110, 2016, https://doi.org/10.1016/j.neuropharm.2016.08.011
- Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities pp.1708-8283, 2019, https://doi.org/10.1177/0883073819828587
- Niemann–Pick type C disease: cellular pathology and pharmacotherapy vol.153, pp.6, 2014, https://doi.org/10.1111/jnc.14895
- Understanding and Treating Niemann–Pick Type C Disease: Models Matter vol.21, pp.23, 2014, https://doi.org/10.3390/ijms21238979
- The rapidly evolving view of lysosomal storage diseases vol.13, pp.2, 2014, https://doi.org/10.15252/emmm.202012836